Advertisement
Advertisement

QTTB

QTTB logo

Q32 Bio Inc. Common Stock

11.55
USD
Sponsored
+0.39
+3.54%
Jun 25, 13:51 UTC -4
Open

QTTB Earnings Reports

Positive Surprise Ratio

QTTB beat 17 of 33 last estimates.

52%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.56
Implied change from Q1 26 (Revenue/ EPS)
--
/
+3.70%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-28.21%

Q32 Bio Inc. Common Stock earnings per share and revenue

On May 05, 2026, QTTB reported earnings of -0.54 USD per share (EPS) for Q1 26, beating the estimate of -0.69 USD, resulting in a 22.15% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.56 USD, with revenue projected to reach -- USD, implying an increase of 3.70% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Q32 Bio Inc. Common Stock reported EPS of -$0.54, beating estimates by 22.15%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.98%, changed from $5.04 before the earnings release to $5.14 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 3 analysts, Q32 Bio Inc. Common Stock is expected to report EPS of -$0.56 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement